-
Mashup Score: 1Novel Monoclonal Antibody Which Targets Tau Protein Accumulation Receives IND Clearance from FDA - Practical Neurology - 7 month(s) ago
Oscotec (Seognam, South Korea) and ADEL (Seoul, South Korea) announced that their investigational new drug (IND) application for ADEL-Y01, a novel IgG
Source: practicalneurology.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0Revolutionizing Monoclonal Antibody Production Monitoring - 1 year(s) ago
The team hopes to develop an integrated protein chip instrument within the next few years.
Categories: Future of Medicine, Latest HeadlinesTweet-
Revolutionizing Monoclonal Antibody Production Monitoring Swedish researchers have developed a microfluidic chip that they hope will allow for easier monitoring of #monoclonalantibody (#mAb) production. Learn more: https://t.co/b0ThTWwPR2 https://t.co/3yRpL07u2B
-
-
Mashup Score: 2Revolutionizing Monoclonal Antibody Production Monitoring - 1 year(s) ago
The team hopes to develop an integrated protein chip instrument within the next few years.
Categories: Future of Medicine, Latest HeadlinesTweet-
Revolutionizing Monoclonal Antibody Production Monitoring Swedish researchers have developed a microfluidic chip that they hope will allow for easier monitoring of #monoclonalantibody (#mAb) production. Learn more: https://t.co/b0ThTWwPR2 https://t.co/waAmKp9C39
-
-
Mashup Score: 1Revolutionizing Monoclonal Antibody Production Monitoring - 1 year(s) ago
The team hopes to develop an integrated protein chip instrument within the next few years.
Categories: Future of Medicine, Latest HeadlinesTweet-
Revolutionizing Monoclonal Antibody Production Monitoring Swedish researchers have developed a microfluidic chip that they hope will allow for easier monitoring of #monoclonalantibody (#mAb) production. Learn more: https://t.co/b0ThTWwPR2 https://t.co/qyAX7tVRFR
-
-
Mashup Score: 4
Annals of Surgical Oncology –
Source: SpringerLinkCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Can oregovomab help improve survival for patients with advanced #OvarianCancer who have undergone surgery? #GynOnc #MonoclonalAntibody @AnnSurgOncol @NCICCR_SurgOnc https://t.co/ge2cd3SQZe https://t.co/IzUGMUArkV
-
-
Mashup Score: 0Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy: A Cohort Study: Annals of Internal Medicine: Vol 0, No 0 - 1 year(s) ago
Background: Monoclonal antibody (mAb) treatment decreases hospitalization and death in high-risk outpatients with mild to moderate COVID-19. However, no studies have evaluated adverse events and effectiveness of mAbs in pregnant persons compared with no mAb treatment. Objective: To determine the frequency of drug-related adverse events and obstetric-associated safety outcomes after treatment with…
Source: Annals of Internal MedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
New from @ErinMcCreary @UPMCnews: #MonoclonalAntibody treatment for mild/moderate #COVID19 is safe for clinical use. Reported adverse effects were also rare and mild https://t.co/YpCwOrmHZM https://t.co/klTBHfefDX
-
-
Mashup Score: 0Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy: A Cohort Study: Annals of Internal Medicine: Vol 0, No 0 - 1 year(s) ago
Background: Monoclonal antibody (mAb) treatment decreases hospitalization and death in high-risk outpatients with mild to moderate COVID-19. However, no studies have evaluated adverse events and effectiveness of mAbs in pregnant persons compared with no mAb treatment. Objective: To determine the frequency of drug-related adverse events and obstetric-associated safety outcomes after treatment with…
Source: Annals of Internal MedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
New from @ErinMcCreary @UPMCnews: #MonoclonalAntibody treatment for mild/moderate #COVID19 is safe for clinical use. Reported adverse effects were also rare and mild https://t.co/YpCwOrmHZM https://t.co/obFzlCjzmp
-
-
Mashup Score: 0Fight Cat Allergies With Newest Asthma Drug? - 2 year(s) ago
SCIT boosted with tezepelumab made it easier to tolerate cats, or at least allergies to them
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Allergic to cats? Hear meow-t. š± SCIT for reducing #catallergy symptoms appeared to be more effective and longer lasting with the help of #tezepelumab (#Tezspire), a #monoclonalantibody recently approved for severe #asthma: https://t.co/V0S8W4X1oo
-
-
Mashup Score: 2Join our Cloud HD Video Meeting - 2 year(s) ago
Zoom is the leader in modern enterprise video communications, with an easy, reliable cloud platform for video and audio conferencing, chat, and webinars across mobile, desktop, and room systems. Zoom Rooms is the original software-based conference room solution used around the world in board, conference, huddle, and training rooms, as well as executive offices and classrooms. Founded in 2011,…
Source: Zoom VideoCategories: Hospital-Based Medicine, Latest HeadlinesTweet-
RT @RealTimeCOVID19: Join @HHSGov TODAY 2-3 EST for an update on #monoclonalantibody distribution https://t.co/rYoGWyRDpv #RealTimeCOVID19ā¦
-
-
Mashup Score: 1
A CLL patient describes his experience getting a Regeneron monoclonal antibody infusion after being exposed to COVID-19.
Source: Patient PowerCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
My Regeneron #MonoclonalAntibody Infusion Experience After Paul Kane was exposed to COVID-19, he received an emergency infusion of Regeneron monoclonal antibodies, which were recently approved by the FDA for use in immunocompromised people. More: https://t.co/hjj7Hlqsad #leusm
-
Novel tau proteinātargeting #MonoclonalAntibody ADEL-Y01, jointly developed by Oscotec and ADEL, has received IND clearance from the @US_FDA. https://t.co/TOJm4S9OkE https://t.co/PeKKAnczi0